VetCPD is grateful for the support of the following companies

Blog

Jul 30
Stelfonta

Virbac Launches STELFONTA®, a Ground-Breaking New Treatment for Canine Mast Cell Tumours (MCTs)

Virbac is pleased to announce the launch of STELFONTA®, a breakthrough injectable solution to treat mastocytoma in dogs.  STELFONTA® is licensed for the treatment of non-resectable, non-metastatic (WHO staging; Garrett, 2014) subcutaneous MCTs located at or distal to the elbow or the hock, and non-resectable, non-metastatic cutaneous MCTs in dogs.... read more →
1